A carregar...

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

Modified vaccinia virus Ankara (MVA), developed >30 years ago as a highly attenuated candidate smallpox vaccine, was recloned from a 1974 passage and evaluated for safety and immunogenicity. Replication of MVA is impaired in most mammalian cells, and we found that mice with severe combined immuno...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wyatt, Linda S., Earl, Patricia L., Eller, Leigh Anne, Moss, Bernard
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2004
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC384791/
https://ncbi.nlm.nih.gov/pubmed/15070762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0401165101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!